Oncocyte $OCX — 
📌 Prospective, blinded clinical validation study didnt achieve pre-defined endpoint of improvement
📌now focus on accelerating DetermaRx™ &amp; DetermaI being commercialized for the clinical &amp; biopharma mkts

#healthcare #stocks #investment
 https://t.co/8JNgyxkmaG